Table 3.
A Comparative view of this study (Fars-Iran) with Croatia and Ukraine
|
| |||||
| IGF-2 Genotype | Control | Patient | OR | P-value | |
| A/G genotype | |||||
| Iran | 18 (36), n = 50 | 27 (54), n = 50 | 3.274 | 0.04 | |
| Croatia | 28 (24.8), n = 113 | 54 (47.8), n = 113 | 3.274 | 0.0001 | |
| Ukraine | 9 (0.225), n = 40 | 74 (0.692), n = 107 | 7.7239 | 0.01 | |
| G/G genotype | |||||
| Iran | 7 (14), n = 50 | 11 (22), n = 50 | 1.048 | 0.935 | |
| Croatia | 22 (19.5), n = 113 | 44 (38.9), n = 113 | - 0.0001 | ||
| Ukraine | 27 (0.675), n = 40 | 22 (0.206), n = 107 | - 0.0001 | ||
| Data presented as n (%); OR and P-value by Fisher's exact test | |||||